Human Microbiome Therapeutics Market Size Worth USD 1,098.4 Million by 2027 | Rising Government Initiatives In Microbiome Research Projects And Increasing Drug-Related Side Effects Are Driving The Industry Growth, says Emergen Research

Vancouver, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- The global Human Microbiome Therapeutics Market is forecasted to be worth USD 1,098.4 Million by 2027, according to a current analysis by Emergen Research. Due to the rising government initiatives in microbiome research projects to prevent infectious diseases, the market of human microbiome therapeutics is expected to grow exponentially over the forecast timeframe. Besides, the increasing issues of drug-related adverse effects on the human body are also anticipated to drive the market growth shortly.

However, the strict legal standards for the manufacturing of products and the selling of the products are expected to hinder the market growth during the forecast timeline.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/280

Key Highlights From The Report

• In October 2017, Crestovo and Finch Therapeutics announced a merger to establish the Finch Therapeutics Group. Finch Therapeutics Group, the latest company, incorporates the vast IP assets of Crestovo and the late-stage candidate for recurring C. difficile diseases, CP101, an oral Full-Spectrum Microbiota product with the commercial-scale processing capability of Finch, a Rationally-Selected Microbiota production tool and an effective product pipeline.
• As prebiotics are non-digestible carbohydrates that help the production of microbes in the body, the Prebiotics segment is expected to experience steady growth over the forecasted time period.
• Due to the incidence of antibiotic cross-reactions and the change in lifestyle and unhealthy eating habits, the C. difficile segment is anticipated to hold the largest market over the forecast timeline.
• Due to the growing prevalence of C-difficile and intestinal bowel disorders, metabolic disorders are expected to undergo substantial growth over the forecast timeframe.
• The Asia Pacific is anticipated to be the fastest-growing regional market over the forecast timeframe. In Asian countries such as China, South Korea, Japan, India, and Australia, a sudden rise in COVID-19 cases is the main driver to demand in this region. India and China are the countries with the highest population sizes; hence the number of people infected by infectious diseases is high.
• Key participants include Oxidien Pharmaceuticals, LLC, BiomX Ltd., LNC Therapeutics SA, Commense Inc, Embion Technologies SA, DermBiont, Inc, CoreBiome, Inc., Carbiotix AB, Biotagenics Inc., and Finch Therapeutics, among others.

Check Our Prices@ https://www.emergenresearch.com/select-license/280
Emergen Research has segmented the global Human Microbiome Therapeutics Market on the basis of product, approach, therapeutic areas, diseases, and region:

• Product Outlook (Revenue, USD Million; 2017-2027)
  • Prescription Drugs
  • Probiotics
  • Medical Foods
  • Prebiotics
• Approach Outlook (Revenue, USD Million; 2017-2027)
  • Microbial Consortia
  • Phage Cocktail
  • Small Molecule Therapies
  • Microbial Ecosystems
  • Genetically Modified Single Strain Bacteria
  • Single Strain Whole Bacteria
• Therapeutic Areas Outlook (Revenue, USD Million; 2017-2027)
  • Oncology
  • Autoimmune Disorders
  • Dermatological Disorders
  • Metabolic Disorders
  • Infectious Disease
  • Others
• Diseases Outlook (Revenue, USD Million; 2017-2027)
  • Crohn’s Disease
  • C. difficile
  • Diabetes
  • Irritable Bowel Syndrome
  • Others

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/human-microbiome-therapeutics-market

• Regional Outlook (Revenue, USD Million; 2017-2027)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-human-microbiome-therapeutics-market